Thrombocytopenia: epidemiology, potential complications and emerging treatments
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Biomedical
[2014]
|
| Schriftenreihe: | Recent advances in hematology research series
|
| Schlagworte: | |
| Beschreibung: | Online resource; title from PDF title page (Ebsco, viewed September 17, 2014) |
| Beschreibung: | 1 online resource |
| ISBN: | 9781633217423 1633217426 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044358588 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170620s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9781633217423 |9 978-1-63321-742-3 | ||
| 020 | |a 1633217426 |9 1-63321-742-6 | ||
| 035 | |a (ZDB-4-NLEBK)ocn890737030 | ||
| 035 | |a (OCoLC)890737030 | ||
| 035 | |a (DE-599)BVBBV044358588 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.157 |2 23 | |
| 245 | 1 | 0 | |a Thrombocytopenia |b epidemiology, potential complications and emerging treatments |c Mckenzie G. Bell, editor |
| 264 | 1 | |a New York |b Nova Biomedical |c [2014] | |
| 300 | |a 1 online resource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Recent advances in hematology research series | |
| 500 | |a Online resource; title from PDF title page (Ebsco, viewed September 17, 2014) | ||
| 505 | 8 | |a Preface; Chapter 1; Immune Thrombocytopenic; Purpura (ITP) in Adults; Alida Podrumar, MD1, (, Gita Lisker, MD2, ; Debra A. Ferman, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, NY, US; Abstract; Epidemiology; Definition; Clincial Presentation; Diagnosis; Laboratory Testing; Differential Diagnosis; Pathophysiology; Who Should Be Treated?; Initial Therapy in ITP; Second Line Therapy in ITP; Rituximab; Splenectomy; Thrombopoietin Receptor Agonists (TPO-RA); Refractory ITP. | |
| 505 | 8 | |a What Second Line Therapy Should I Choose?ITP in Pregnancy; Emergency Bleeding in ITP; Conclusion; References; Chapter 2; The Approach to Thrombocytopenia; in the Hospital Setting: A Primer; for the General Internist; Debra A. Ferman, MD1, (, Gita Lisker, MD2, ; Alida Podrumar, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, New Hyde Park, NY, US; Abstract; Introduction; Part 1: Acquired Thrombocytopenia; in the Hospital Setting: Bugs or Drugs; Introduction; Infection; Drug Induced Thrombocytopenia | |
| 505 | 8 | |a Special Cases -- Individual DrugsOxaliplatin Induced Thrombocytopenia; Heparin Induced Thrombocytopenia (HIT); Post-Transfusion Purpura; Disseminated Intravascular Coagulation (DIC); Dilutional Thrombocytopenia; Mechanical Intravascular Devices -- Cardiac Bypass Pump, Intraaortic Balloon Pump; Cardiac Bypass Pump (CBP); Intraaortic Balloon Pump (IABP); Part 2: Thrombocytopenia; Present Prior to the Hospitalization; Pseudothrombocytopenia | |
| 505 | 8 | |a Thrombotic Microangiopathies (TMA): Thrombocytopenic Thrombotic Purpura (TTP)/Typical Hemolytic Uremic Syndrome (HUS)/Atypical Hemolytic Uremic Syndrome (aHUS)TTP; Typical HUS; Atypical HUS; Special Categories of TTP; Hematopoietic Stem Cell Transplantation-Associated TMA; Drug Associated TTP; Drugs Associated with HUS; HIV Associated TTP; Malignancy Associated TMA; Pancreatitis Associated TTP; Antiphospholipid Syndrome (APS); Evans Syndrome; Immune Thrombocytopenia: See Part 3; Type 2B Von Willebrand Disease; Congenital Thrombocytopenia; Liver Disease: Hepatitis, Hypersplenism | |
| 505 | 8 | |a Massive SplenomegalyBone Marrow Disorders: Myelodysplastic Syndrome (MDS), Leukemia, Lymphoma, Multiple Myeloma; Infections Obtained Prior to Hospitalization; Tickborne Illness; Recent Vaccines; Ingestions; Quinine Induced Thrombocytopenia (QITP); Schezwan Purpura; Alcohol; Vitamin B12 or Folate Deficiency; Advanced Malignancy; Part 3: Causes for a Platelet Count Less Than 10,000/mm3; Immune Thrombocytopenia (ITP); ITP secondary to Hepatitis C; ITP secondary to HIV; ITP associated with H. Pylori; Drug Induced Thrombocytopenia: Glycoprotein IIb/IIIa Antagonists | |
| 505 | 8 | |a Decreased platelet counts can be due to a number of disease processes causing decreased platelet production, increased platelet destruction, or can be medication-induced. Health care providers have to differentiate inherited thrombocytopenias, primary immune thrombocytopenias (ITP), secondary immune thrombocytopenias, myelodysplastic syndromes with thrombocytopenia, bone marrow failure syndromes and non-immune thrombocytopenias. ITP is the most common cause of isolated thrombocytopenia. This book focuses on discussing ITP in adults; new treatment for ITP; thrombocytopenia during pregnancy; the | |
| 650 | 4 | |a Heparin / Side effects | |
| 650 | 4 | |a Hypertension | |
| 650 | 4 | |a Thrombocytopenia | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Hematology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Thrombocytopenia |x Diagnosis |a Thrombocytopenia |x Treatment | |
| 700 | 1 | |a Bell, Mckenzie G. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Thrombocytopenia |z 1633217132 |z 9781633217133 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029761219 | ||
Datensatz im Suchindex
| _version_ | 1804177604468539392 |
|---|---|
| any_adam_object | |
| author2 | Bell, Mckenzie G. |
| author2_role | edt |
| author2_variant | m g b mg mgb |
| author_facet | Bell, Mckenzie G. |
| building | Verbundindex |
| bvnumber | BV044358588 |
| collection | ZDB-4-NLEBK |
| contents | Preface; Chapter 1; Immune Thrombocytopenic; Purpura (ITP) in Adults; Alida Podrumar, MD1, (, Gita Lisker, MD2, ; Debra A. Ferman, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, NY, US; Abstract; Epidemiology; Definition; Clincial Presentation; Diagnosis; Laboratory Testing; Differential Diagnosis; Pathophysiology; Who Should Be Treated?; Initial Therapy in ITP; Second Line Therapy in ITP; Rituximab; Splenectomy; Thrombopoietin Receptor Agonists (TPO-RA); Refractory ITP. What Second Line Therapy Should I Choose?ITP in Pregnancy; Emergency Bleeding in ITP; Conclusion; References; Chapter 2; The Approach to Thrombocytopenia; in the Hospital Setting: A Primer; for the General Internist; Debra A. Ferman, MD1, (, Gita Lisker, MD2, ; Alida Podrumar, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, New Hyde Park, NY, US; Abstract; Introduction; Part 1: Acquired Thrombocytopenia; in the Hospital Setting: Bugs or Drugs; Introduction; Infection; Drug Induced Thrombocytopenia Special Cases -- Individual DrugsOxaliplatin Induced Thrombocytopenia; Heparin Induced Thrombocytopenia (HIT); Post-Transfusion Purpura; Disseminated Intravascular Coagulation (DIC); Dilutional Thrombocytopenia; Mechanical Intravascular Devices -- Cardiac Bypass Pump, Intraaortic Balloon Pump; Cardiac Bypass Pump (CBP); Intraaortic Balloon Pump (IABP); Part 2: Thrombocytopenia; Present Prior to the Hospitalization; Pseudothrombocytopenia Thrombotic Microangiopathies (TMA): Thrombocytopenic Thrombotic Purpura (TTP)/Typical Hemolytic Uremic Syndrome (HUS)/Atypical Hemolytic Uremic Syndrome (aHUS)TTP; Typical HUS; Atypical HUS; Special Categories of TTP; Hematopoietic Stem Cell Transplantation-Associated TMA; Drug Associated TTP; Drugs Associated with HUS; HIV Associated TTP; Malignancy Associated TMA; Pancreatitis Associated TTP; Antiphospholipid Syndrome (APS); Evans Syndrome; Immune Thrombocytopenia: See Part 3; Type 2B Von Willebrand Disease; Congenital Thrombocytopenia; Liver Disease: Hepatitis, Hypersplenism Massive SplenomegalyBone Marrow Disorders: Myelodysplastic Syndrome (MDS), Leukemia, Lymphoma, Multiple Myeloma; Infections Obtained Prior to Hospitalization; Tickborne Illness; Recent Vaccines; Ingestions; Quinine Induced Thrombocytopenia (QITP); Schezwan Purpura; Alcohol; Vitamin B12 or Folate Deficiency; Advanced Malignancy; Part 3: Causes for a Platelet Count Less Than 10,000/mm3; Immune Thrombocytopenia (ITP); ITP secondary to Hepatitis C; ITP secondary to HIV; ITP associated with H. Pylori; Drug Induced Thrombocytopenia: Glycoprotein IIb/IIIa Antagonists Decreased platelet counts can be due to a number of disease processes causing decreased platelet production, increased platelet destruction, or can be medication-induced. Health care providers have to differentiate inherited thrombocytopenias, primary immune thrombocytopenias (ITP), secondary immune thrombocytopenias, myelodysplastic syndromes with thrombocytopenia, bone marrow failure syndromes and non-immune thrombocytopenias. ITP is the most common cause of isolated thrombocytopenia. This book focuses on discussing ITP in adults; new treatment for ITP; thrombocytopenia during pregnancy; the |
| ctrlnum | (ZDB-4-NLEBK)ocn890737030 (OCoLC)890737030 (DE-599)BVBBV044358588 |
| dewey-full | 616.157 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.157 |
| dewey-search | 616.157 |
| dewey-sort | 3616.157 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05163nmm a2200553zc 4500</leader><controlfield tag="001">BV044358588</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170620s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781633217423</subfield><subfield code="9">978-1-63321-742-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1633217426</subfield><subfield code="9">1-63321-742-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)ocn890737030</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)890737030</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044358588</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.157</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thrombocytopenia</subfield><subfield code="b">epidemiology, potential complications and emerging treatments</subfield><subfield code="c">Mckenzie G. Bell, editor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Biomedical</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Recent advances in hematology research series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Online resource; title from PDF title page (Ebsco, viewed September 17, 2014)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Preface; Chapter 1; Immune Thrombocytopenic; Purpura (ITP) in Adults; Alida Podrumar, MD1, (, Gita Lisker, MD2, ; Debra A. Ferman, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, NY, US; Abstract; Epidemiology; Definition; Clincial Presentation; Diagnosis; Laboratory Testing; Differential Diagnosis; Pathophysiology; Who Should Be Treated?; Initial Therapy in ITP; Second Line Therapy in ITP; Rituximab; Splenectomy; Thrombopoietin Receptor Agonists (TPO-RA); Refractory ITP.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">What Second Line Therapy Should I Choose?ITP in Pregnancy; Emergency Bleeding in ITP; Conclusion; References; Chapter 2; The Approach to Thrombocytopenia; in the Hospital Setting: A Primer; for the General Internist; Debra A. Ferman, MD1, (, Gita Lisker, MD2, ; Alida Podrumar, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, New Hyde Park, NY, US; Abstract; Introduction; Part 1: Acquired Thrombocytopenia; in the Hospital Setting: Bugs or Drugs; Introduction; Infection; Drug Induced Thrombocytopenia</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Special Cases -- Individual DrugsOxaliplatin Induced Thrombocytopenia; Heparin Induced Thrombocytopenia (HIT); Post-Transfusion Purpura; Disseminated Intravascular Coagulation (DIC); Dilutional Thrombocytopenia; Mechanical Intravascular Devices -- Cardiac Bypass Pump, Intraaortic Balloon Pump; Cardiac Bypass Pump (CBP); Intraaortic Balloon Pump (IABP); Part 2: Thrombocytopenia; Present Prior to the Hospitalization; Pseudothrombocytopenia</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Thrombotic Microangiopathies (TMA): Thrombocytopenic Thrombotic Purpura (TTP)/Typical Hemolytic Uremic Syndrome (HUS)/Atypical Hemolytic Uremic Syndrome (aHUS)TTP; Typical HUS; Atypical HUS; Special Categories of TTP; Hematopoietic Stem Cell Transplantation-Associated TMA; Drug Associated TTP; Drugs Associated with HUS; HIV Associated TTP; Malignancy Associated TMA; Pancreatitis Associated TTP; Antiphospholipid Syndrome (APS); Evans Syndrome; Immune Thrombocytopenia: See Part 3; Type 2B Von Willebrand Disease; Congenital Thrombocytopenia; Liver Disease: Hepatitis, Hypersplenism</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Massive SplenomegalyBone Marrow Disorders: Myelodysplastic Syndrome (MDS), Leukemia, Lymphoma, Multiple Myeloma; Infections Obtained Prior to Hospitalization; Tickborne Illness; Recent Vaccines; Ingestions; Quinine Induced Thrombocytopenia (QITP); Schezwan Purpura; Alcohol; Vitamin B12 or Folate Deficiency; Advanced Malignancy; Part 3: Causes for a Platelet Count Less Than 10,000/mm3; Immune Thrombocytopenia (ITP); ITP secondary to Hepatitis C; ITP secondary to HIV; ITP associated with H. Pylori; Drug Induced Thrombocytopenia: Glycoprotein IIb/IIIa Antagonists</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Decreased platelet counts can be due to a number of disease processes causing decreased platelet production, increased platelet destruction, or can be medication-induced. Health care providers have to differentiate inherited thrombocytopenias, primary immune thrombocytopenias (ITP), secondary immune thrombocytopenias, myelodysplastic syndromes with thrombocytopenia, bone marrow failure syndromes and non-immune thrombocytopenias. ITP is the most common cause of isolated thrombocytopenia. This book focuses on discussing ITP in adults; new treatment for ITP; thrombocytopenia during pregnancy; the</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heparin / Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombocytopenia</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Hematology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombocytopenia</subfield><subfield code="x">Diagnosis</subfield><subfield code="a">Thrombocytopenia</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bell, Mckenzie G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="t">Thrombocytopenia</subfield><subfield code="z">1633217132</subfield><subfield code="z">9781633217133</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029761219</subfield></datafield></record></collection> |
| id | DE-604.BV044358588 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:50:43Z |
| institution | BVB |
| isbn | 9781633217423 1633217426 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029761219 |
| oclc_num | 890737030 |
| open_access_boolean | |
| physical | 1 online resource |
| psigel | ZDB-4-NLEBK |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Nova Biomedical |
| record_format | marc |
| series2 | Recent advances in hematology research series |
| spelling | Thrombocytopenia epidemiology, potential complications and emerging treatments Mckenzie G. Bell, editor New York Nova Biomedical [2014] 1 online resource txt rdacontent c rdamedia cr rdacarrier Recent advances in hematology research series Online resource; title from PDF title page (Ebsco, viewed September 17, 2014) Preface; Chapter 1; Immune Thrombocytopenic; Purpura (ITP) in Adults; Alida Podrumar, MD1, (, Gita Lisker, MD2, ; Debra A. Ferman, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, NY, US; Abstract; Epidemiology; Definition; Clincial Presentation; Diagnosis; Laboratory Testing; Differential Diagnosis; Pathophysiology; Who Should Be Treated?; Initial Therapy in ITP; Second Line Therapy in ITP; Rituximab; Splenectomy; Thrombopoietin Receptor Agonists (TPO-RA); Refractory ITP. What Second Line Therapy Should I Choose?ITP in Pregnancy; Emergency Bleeding in ITP; Conclusion; References; Chapter 2; The Approach to Thrombocytopenia; in the Hospital Setting: A Primer; for the General Internist; Debra A. Ferman, MD1, (, Gita Lisker, MD2, ; Alida Podrumar, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, New Hyde Park, NY, US; Abstract; Introduction; Part 1: Acquired Thrombocytopenia; in the Hospital Setting: Bugs or Drugs; Introduction; Infection; Drug Induced Thrombocytopenia Special Cases -- Individual DrugsOxaliplatin Induced Thrombocytopenia; Heparin Induced Thrombocytopenia (HIT); Post-Transfusion Purpura; Disseminated Intravascular Coagulation (DIC); Dilutional Thrombocytopenia; Mechanical Intravascular Devices -- Cardiac Bypass Pump, Intraaortic Balloon Pump; Cardiac Bypass Pump (CBP); Intraaortic Balloon Pump (IABP); Part 2: Thrombocytopenia; Present Prior to the Hospitalization; Pseudothrombocytopenia Thrombotic Microangiopathies (TMA): Thrombocytopenic Thrombotic Purpura (TTP)/Typical Hemolytic Uremic Syndrome (HUS)/Atypical Hemolytic Uremic Syndrome (aHUS)TTP; Typical HUS; Atypical HUS; Special Categories of TTP; Hematopoietic Stem Cell Transplantation-Associated TMA; Drug Associated TTP; Drugs Associated with HUS; HIV Associated TTP; Malignancy Associated TMA; Pancreatitis Associated TTP; Antiphospholipid Syndrome (APS); Evans Syndrome; Immune Thrombocytopenia: See Part 3; Type 2B Von Willebrand Disease; Congenital Thrombocytopenia; Liver Disease: Hepatitis, Hypersplenism Massive SplenomegalyBone Marrow Disorders: Myelodysplastic Syndrome (MDS), Leukemia, Lymphoma, Multiple Myeloma; Infections Obtained Prior to Hospitalization; Tickborne Illness; Recent Vaccines; Ingestions; Quinine Induced Thrombocytopenia (QITP); Schezwan Purpura; Alcohol; Vitamin B12 or Folate Deficiency; Advanced Malignancy; Part 3: Causes for a Platelet Count Less Than 10,000/mm3; Immune Thrombocytopenia (ITP); ITP secondary to Hepatitis C; ITP secondary to HIV; ITP associated with H. Pylori; Drug Induced Thrombocytopenia: Glycoprotein IIb/IIIa Antagonists Decreased platelet counts can be due to a number of disease processes causing decreased platelet production, increased platelet destruction, or can be medication-induced. Health care providers have to differentiate inherited thrombocytopenias, primary immune thrombocytopenias (ITP), secondary immune thrombocytopenias, myelodysplastic syndromes with thrombocytopenia, bone marrow failure syndromes and non-immune thrombocytopenias. ITP is the most common cause of isolated thrombocytopenia. This book focuses on discussing ITP in adults; new treatment for ITP; thrombocytopenia during pregnancy; the Heparin / Side effects Hypertension Thrombocytopenia HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Hematology bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Evidenz-basierte Medizin Innere Medizin Medizin Thrombocytopenia Diagnosis Thrombocytopenia Treatment Bell, Mckenzie G. edt Erscheint auch als Druck-Ausgabe Thrombocytopenia 1633217132 9781633217133 |
| spellingShingle | Thrombocytopenia epidemiology, potential complications and emerging treatments Preface; Chapter 1; Immune Thrombocytopenic; Purpura (ITP) in Adults; Alida Podrumar, MD1, (, Gita Lisker, MD2, ; Debra A. Ferman, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, NY, US; Abstract; Epidemiology; Definition; Clincial Presentation; Diagnosis; Laboratory Testing; Differential Diagnosis; Pathophysiology; Who Should Be Treated?; Initial Therapy in ITP; Second Line Therapy in ITP; Rituximab; Splenectomy; Thrombopoietin Receptor Agonists (TPO-RA); Refractory ITP. What Second Line Therapy Should I Choose?ITP in Pregnancy; Emergency Bleeding in ITP; Conclusion; References; Chapter 2; The Approach to Thrombocytopenia; in the Hospital Setting: A Primer; for the General Internist; Debra A. Ferman, MD1, (, Gita Lisker, MD2, ; Alida Podrumar, MD1,! and Alan S. Multz, MD1,; 1Nassau University Medical Center, East Meadow, NY, US; 2North Shore Long Island Jewish Health System, New Hyde Park, NY, US; Abstract; Introduction; Part 1: Acquired Thrombocytopenia; in the Hospital Setting: Bugs or Drugs; Introduction; Infection; Drug Induced Thrombocytopenia Special Cases -- Individual DrugsOxaliplatin Induced Thrombocytopenia; Heparin Induced Thrombocytopenia (HIT); Post-Transfusion Purpura; Disseminated Intravascular Coagulation (DIC); Dilutional Thrombocytopenia; Mechanical Intravascular Devices -- Cardiac Bypass Pump, Intraaortic Balloon Pump; Cardiac Bypass Pump (CBP); Intraaortic Balloon Pump (IABP); Part 2: Thrombocytopenia; Present Prior to the Hospitalization; Pseudothrombocytopenia Thrombotic Microangiopathies (TMA): Thrombocytopenic Thrombotic Purpura (TTP)/Typical Hemolytic Uremic Syndrome (HUS)/Atypical Hemolytic Uremic Syndrome (aHUS)TTP; Typical HUS; Atypical HUS; Special Categories of TTP; Hematopoietic Stem Cell Transplantation-Associated TMA; Drug Associated TTP; Drugs Associated with HUS; HIV Associated TTP; Malignancy Associated TMA; Pancreatitis Associated TTP; Antiphospholipid Syndrome (APS); Evans Syndrome; Immune Thrombocytopenia: See Part 3; Type 2B Von Willebrand Disease; Congenital Thrombocytopenia; Liver Disease: Hepatitis, Hypersplenism Massive SplenomegalyBone Marrow Disorders: Myelodysplastic Syndrome (MDS), Leukemia, Lymphoma, Multiple Myeloma; Infections Obtained Prior to Hospitalization; Tickborne Illness; Recent Vaccines; Ingestions; Quinine Induced Thrombocytopenia (QITP); Schezwan Purpura; Alcohol; Vitamin B12 or Folate Deficiency; Advanced Malignancy; Part 3: Causes for a Platelet Count Less Than 10,000/mm3; Immune Thrombocytopenia (ITP); ITP secondary to Hepatitis C; ITP secondary to HIV; ITP associated with H. Pylori; Drug Induced Thrombocytopenia: Glycoprotein IIb/IIIa Antagonists Decreased platelet counts can be due to a number of disease processes causing decreased platelet production, increased platelet destruction, or can be medication-induced. Health care providers have to differentiate inherited thrombocytopenias, primary immune thrombocytopenias (ITP), secondary immune thrombocytopenias, myelodysplastic syndromes with thrombocytopenia, bone marrow failure syndromes and non-immune thrombocytopenias. ITP is the most common cause of isolated thrombocytopenia. This book focuses on discussing ITP in adults; new treatment for ITP; thrombocytopenia during pregnancy; the Heparin / Side effects Hypertension Thrombocytopenia HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Hematology bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Evidenz-basierte Medizin Innere Medizin Medizin Thrombocytopenia Diagnosis Thrombocytopenia Treatment |
| title | Thrombocytopenia epidemiology, potential complications and emerging treatments |
| title_auth | Thrombocytopenia epidemiology, potential complications and emerging treatments |
| title_exact_search | Thrombocytopenia epidemiology, potential complications and emerging treatments |
| title_full | Thrombocytopenia epidemiology, potential complications and emerging treatments Mckenzie G. Bell, editor |
| title_fullStr | Thrombocytopenia epidemiology, potential complications and emerging treatments Mckenzie G. Bell, editor |
| title_full_unstemmed | Thrombocytopenia epidemiology, potential complications and emerging treatments Mckenzie G. Bell, editor |
| title_short | Thrombocytopenia |
| title_sort | thrombocytopenia epidemiology potential complications and emerging treatments |
| title_sub | epidemiology, potential complications and emerging treatments |
| topic | Heparin / Side effects Hypertension Thrombocytopenia HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Hematology bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Evidenz-basierte Medizin Innere Medizin Medizin Thrombocytopenia Diagnosis Thrombocytopenia Treatment |
| topic_facet | Heparin / Side effects Hypertension Thrombocytopenia HEALTH & FITNESS / Diseases / General MEDICAL / Hematology MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Evidenz-basierte Medizin Innere Medizin Medizin Thrombocytopenia Diagnosis Thrombocytopenia Treatment |
| work_keys_str_mv | AT bellmckenzieg thrombocytopeniaepidemiologypotentialcomplicationsandemergingtreatments |